Skip to main content
. 2021 Jan 22;6(3):100654. doi: 10.1016/j.adro.2021.100654

Table 3.

Comparison of dose metrics between MRIdian-Linac PTV3mm and CT-Linac PTV10mm plans

Variables MRIdian-Linac PTV3mm Average (SD) CT-Linac PTV3mm Average (SD) P-value
Whole breast metrics
Ipsilateral breast volume (cm3) 671.8 (360.0) 751.0 (414.7) .04
V12.3 <50% 34.8% (12.7) 44.4% (10.9) .002
V12.3 (cm3) 219.4 (117) 312.1 (147) .002
PTV metrics
Volume (cm3) 84.3 (51.9) 131.7 (74.4) .002
Ratio of PTV/ipsilateral breast volume 13.0 (5.1) 18.6 (6.4) .002
V23.4 ≥95% 99% (0.9) 97.6% (1.4) .03
D2cc <26.3 Gy 26.1 Gy (0.19) 25.7 Gy (0.33) .01
V26.3 Gy (cm3) 0.9 (1.9) 0.23 (0.67) .06
D2% (Gy) 26.2 (0.17) 25.6 (0.32) .006
D50% (Gy) 25.5 (0.2) 24.8 (0.17) .002
D98% (Gy) 23.8 (0.4) 23.5 (0.1) .08
Max point dose (Gy) 26.8 (0.26) 26.2 (0.36) .01
DHI ratio 0.1 (0) 0.08 (0.01) .02
CI ratio 0.99 (0.03) 0.95 (0.01) .02
R50 ratio 4.6 (1.3) 5.1 (1.4) .5
Skin metrics
Max point dose (Gy) 23.46 (2.09) 22.74 (1.58) .43
Contralateral breast
Point dose (Gy) 0.6 (0.17) 0.7 (0.2) .2
Ipsilateral lung
V7.7<10% 3.7% (2.5) 6.9% (3.2) .02
V2.7<20% 16.7% (6.4) 17.8% (5.3) .99
Mean dose (Gy) 1.64 (0.55) 2.0 (0.5) .06
Contralateral lung
V1.4 <15% 1.9% (3.6) 4.1% (6.1) .64
Mean dose (Gy) 0.32 (0.16) 0.4 (0.22) .54
Total lung
Mean dose (Gy) 0.96 (0.36) 1.2 (0.36) .06
Heart
Mean dose (Gy) 0.4 (0.2) 0.5 (0.2) .6
V4.0 (%) 0.07% (0.2) 0.34% (0.6) .1
V2.6 (%) 0.5% (0.9) 1.7% (2.0) .1
RTOG chest wall
V24 (cm3) 8.5 (5.5) 21.8 (14.9) .004
Max point dose <26 Gy 24.1 Gy (6.2) 23.8 Gy (5.8) .2

Abbreviations: CI = conformality index; D2cm3 = dose to 2 cm3 of the target; DHI = dose homogeneity index; Dmax = maximum dose; Dx = dose to x% of the target; PTV = planning target volume; SD = standard deviation; Vx = dose to x% of the target volume.

Statistically significant.